---
id: CVE-2026-1037
title: >-
  IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART
  9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting
summary: >-
  IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART
  9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This
  vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript
  code in the We…
severity: medium
cvss: 6.1
cvssVector: 'CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N'
cwe:
  - CWE-79
vendor: IBM
product: Common Licensing
affected:
  - common_licensing Agent 9.0
  - common_licensing Agent 9.0.0.1
  - common_licensing Agent 9.0.0.2
  - common_licensing ART 9.0
  - common_licensing ART 9.0.0.1
  - common_licensing ART 9.0.0.2
published: '2026-09-18'
updated: '2026-09-18'
sourceUpdated: '2026-09-18T18:17:47.257'
source: NVD
sourceUrl: 'https://nvd.nist.gov/vuln/detail/CVE-2026-1037'
references:
  - url: 'https://www.ibm.com/support/pages/node/7286490'
    label: psirt@us.ibm.com
tags:
  - nvd
  - cve.org
ssvc:
  exploitation: none
  automatable: 'no'
  technicalImpact: partial
  timestamp: '2026-09-18T16:15:12.882173Z'
ingestedAt: '2026-09-18T16:45:41.384Z'
epss: 0.00275
epssPercentile: 0.20182
---

## Overview

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.

## Remediation

Refer to the linked advisories for vendor-supplied fixes and affected version ranges.
